Case report shows safe spinal anesthesia during cesarean delivery in a woman with dysfibrinogenemia, indicating thromboelastography's role in assessing risks.
Background Dysfibrinogenemia causes abnormal fibrinogen production, leading to thrombotic or bleeding complications, which are relative contraindications for neuraxial anesthesia. Neuraxial anesthesia is recommended for cesarean delivery to reduce maternal and neonatal morbidity. Case presentation We report a 39-year-old gravida 2, para 0 woman with dysfibrinogenemia who safely underwent spinal anesthesia, as assessed using thromboelastography, for an urgent cesarean delivery. Conclusions Thromboelastography can aid the anesthesia team in evaluating the risks versus benefits of neuraxial anesthesia in patients with hereditary dysfibrinogenemia.
No takes yet. Share an insight, caveat, or question.
Ono et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: